PART I INTRODUCTION This information included in this Annual Report should be read in conjunction with the consolidated financial statements and related notes in Item 8. Financial Statements and Supplemental Data of this Annual Report. Our logo and some of our trademarks and tradenames are used in this Annual Report. This Annual Report may also include trademarks, tradenames and service marks that are the property of others. Solely for convenience, trademarks, tradenames and service marks referr...
Q2 FY2026 — expected 2026-09-15
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-30 | 2025-12-31 | 0001493152-26-013475 | EDGAR | 90K words |
| 2025-03-26 | 2024-12-31 | 0001641172-25-000657 | EDGAR | — |
| 2024-04-22 | 2023-12-31 | 0001493152-24-015595 | EDGAR | — |
| 2023-03-27 | 2022-12-31 | 0001493152-23-009090 | EDGAR | — |
| 2022-03-28 | 2021-12-31 | 0001493152-22-007879 | EDGAR | — |
| 2021-03-29 | 2020-12-31 | 0001493152-21-007052 | EDGAR | — |
| 2020-03-30 | 2019-12-31 | 0001493152-20-005026 | EDGAR | — |
| 2019-03-22 | 2018-12-31 | 0001493152-19-003756 | EDGAR | — |
| 2018-03-02 | 2017-12-31 | 0001078782-18-000252 | EDGAR | — |
| 2017-03-30 | 2016-12-31 | 0001078782-17-000381 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-12 | 2025-09-30 | 0001493152-25-022032 | EDGAR | 38K words |
| 2025-08-12 | 2025-06-30 | 0001641172-25-023121 | EDGAR | — |
| 2025-05-12 | 2025-03-31 | 0001641172-25-009771 | EDGAR | — |
| 2024-11-06 | 2024-09-30 | 0001493152-24-043756 | EDGAR | — |
| 2024-08-09 | 2024-06-30 | 0001493152-24-030971 | EDGAR | — |
| 2024-06-26 | 2024-03-31 | 0001493152-24-025217 | EDGAR | — |
| 2024-01-16 | 2023-09-30 | 0001493152-24-002429 | EDGAR | — |
| 2023-08-18 | 2023-06-30 | 0001493152-23-029435 | EDGAR | — |
| 2023-05-15 | 2023-03-31 | 0001493152-23-017524 | EDGAR | — |
| 2022-11-07 | 2022-09-30 | 0001493152-22-030832 | EDGAR | — |
| 2022-07-25 | 2022-06-30 | 0001493152-22-020255 | EDGAR | — |
| 2022-05-09 | 2022-03-31 | 0001493152-22-012529 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2025-11-18 | 0001493152-25-023944 | EDGAR | 1K words |
| 2025-11-14 | 0001493152-25-023614 | EDGAR | — |
| 2025-11-13 | 0001493152-25-022385 | EDGAR | — |
| 2025-10-30 | 0001493152-25-020261 | EDGAR | — |
| 2025-10-24 | 0001493152-25-019341 | EDGAR | — |
| 2025-10-17 | 0001493152-25-018505 | EDGAR | — |
| 2025-10-16 | 0001493152-25-018332 | EDGAR | — |
| 2025-10-06 | 0001493152-25-017117 | EDGAR | — |
| 2025-10-03 | 0001493152-25-016882 | EDGAR | — |
| 2025-09-23 | 0001493152-25-014658 | EDGAR | — |
255 total filings indexed. 223 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001382574 |
| Ticker | SCNX |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.scienture.com |
| Listed | 2008-02-22 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report